JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 6, 2006; DOI: 10.1124/jpet.106.102863


0022-3565/06/3181-79-89$20.00
JPET 318:79-89, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.102863v1
318/1/79    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuzzocrea, S.
Right arrow Articles by Thiemermann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuzzocrea, S.
Right arrow Articles by Thiemermann, C.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Glycogen Synthase Kinase-3beta Inhibition Reduces Secondary Damage in Experimental Spinal Cord Trauma

Salvatore Cuzzocrea, Tiziana Genovese, Emanuela Mazzon, Concetta Crisafulli, Rosanna Di Paola, Carmelo Muià, Marika Collin, Emanuela Esposito, Placido Bramanti, and Christoph Thiemermann

Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (S.C., T.G., E.M., C.C., C.M., R.D.P.); The William Harvey Research Institute, Centre for Experimental Medicine, Nephrology and Critical Care, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, United Kingdom (M.C., C.T.); Istituto di Ricovero e Cura a Carattere Scientifico Centro Neurolesi "Bonino-Pulejo", Messina, Italy (S.C., E.M., P.B., T.G.); and Department of Experimental Pharmacology, University of Naples "Federico II", Naples, Italy (E.E.)

Glycogen synthase kinase-3 (GSK-3) has recently been identified as an ubiquitous serine-threonine protein kinase that participates in a multitude of cellular processes and plays an important role in the pathophysiology of a number of diseases. The aim of this study was to investigate the effects of GSK-3beta inhibition on the degree of experimental spinal cord trauma induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord injury (SCI) in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of a range of inflammatory mediators, tissue damage, and apoptosis. Treatment of the mice with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), a potent and selective GSK-3beta inhibitor, significantly reduced the degree of 1) spinal cord inflammation and tissue injury (histological score); 2) neutrophil infiltration (myeloperoxidase activity); 3) inducible nitric-oxide synthase, nitrotyrosine, and cyclooxygenase-2 expression; and 4) and apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining and Bax and Bcl-2 expression). In a separate set of experiments, TDZD-8 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results clearly demonstrate that treatment with TDZD-8 reduces the development of inflammation and tissue injury associated with spinal cord trauma.


Received February 13, 2006; accepted April 5, 2006.

Address correspondence to: Prof. Salvatore Cuzzocrea, Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Torre Biologica, Policlinico Universitario Via C. Valeria, Gazzi 98100 Messina Italy. E-mail: salvator{at}unime.it




This article has been cited by other articles:


Home page
BrainHome page
S. Ceruti, G. Villa, T. Genovese, E. Mazzon, R. Longhi, P. Rosa, P. Bramanti, S. Cuzzocrea, and M. P. Abbracchio
The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury
Brain, June 15, 2009; (2009) awp147v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Dill, H. Wang, F. Zhou, and S. Li
Inactivation of Glycogen Synthase Kinase 3 Promotes Axonal Growth and Recovery in the CNS
J. Neurosci., September 3, 2008; 28(36): 8914 - 8928.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. De Sarno, R. C. Axtell, C. Raman, K. A. Roth, D. R. Alessi, and R. S. Jope
Lithium Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis
J. Immunol., July 1, 2008; 181(1): 338 - 345.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Guzman, X. Li, C. A. Corbett, R. M. Rossi, T. Bushnell, J. L. Liesveld, J. Hebert, F. Young, and C. T. Jordan
Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)
Blood, December 15, 2007; 110(13): 4436 - 4444.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.